Medication-Assisted Treatment for Opioid Use Disorder and Alcohol Use Disorder

What Is Medication-Assisted Treatment?

Medication-Assisted Treatment (MAT) is an evidence-based approach primarily used to treat individuals who are struggling with substance use disorders, particularly those related to opioids like heroin, fentanyl, opioid-based prescriptions, pain medications, or alcohol. This approach leverages medications and behavioral therapy to ease the withdrawal symptoms and help the patient throughout their detox and recovery. Studies indicate that MAT can reduce the risk of death from substance abuse by more than 50%.

Certain medications have been approved by the US Food and Drug Administration (FDA) to assist with the treatment of substance use disorders for MAT. The behavioral component of MAT involves counseling and therapy to address the underlying psychological aspects of addiction. This can include cognitive-behavioral therapy, family counseling, and other forms of psychotherapy.

Naltrexone And MAT For Opioid Addiction And Alcohol Addiction

Naltrexone is the preferred medication used at the Coleman Institute for Addiction Medicine. We have used Naltrexone Therapy for over 25 years and believe in its efficacy and safety for opioid addiction treatment and alcohol addiction treatment. Since Naltrexone is an opioid antagonist, it blocks the effects of opioids at their receptor sites in the brain. If someone takes opioids after Naltrexone Therapy, they won’t feel the typical euphoric effects. Because naltrexone blocks the euphoric effects of opioids, it can help reduce the desire to use opioids. It’s non-addictive and does not cause physical dependence. It also blocks the euphoric sensation from drinking alcohol.

The Coleman Institute offers two specially formulated, long-acting, slow-release Naltrexone options for patients, depending on their unique circumstances and needs:

• Naltrexone Implant: This small implant is inserted into the fatty tissue of the abdomen via a small, half-inch incision, lasting up to 8 weeks.
• Vivitrol Injection: This injection is administered monthly.

To encourage the development of new, healthier habits and to live a life of sobriety, we recommend 6 to 12 months of Naltrexone Therapy following a detox.

Who Is A Good Candidate For Medication-Assisted Treatment?

Medication-Assisted Treatment (MAT) is primarily used for the treatment of substance use disorders, particularly opioid use disorders (OUD) and alcohol use disorders (AUD). Determining whether someone is a good candidate for MAT and which form of MAT is most appropriate involves a comprehensive assessment by a qualified medical professional, taking into account the individual’s medical history, substance use history, and other factors. Generally, potential candidates for MAT may have the following characteristics:

• Diagnosis of Opioid Use Disorder (OUD): Individuals who have been diagnosed with OUD, whether it’s due to prescription painkillers, heroin, or other opioids, might benefit from MAT.
• Diagnosis of Alcohol Use Disorder (AUD): Individuals who have been diagnosed with AUD may benefit from MAT.
• History of Relapse: MAT can be particularly useful for those who have a history of multiple relapses, as the medications can reduce cravings and block the effects of opioids, making relapse less appealing.
• High Risk of Overdose: Those at high risk of opioid overdose can benefit from MAT to reduce the risk of overdose.
• Commitment to Recovery: MAT is most effective when the individual is motivated and actively participates in the recovery process. This includes adhering to guidelines and engaging in counseling or behavioral therapies.
• Inability to Sustain Abstinence: If an individual has repeatedly tried but been unable to maintain abstinence from opioids or alcohol, they might benefit from the support that MAT provides.

It’s important to note that while MAT can be a valuable tool in the treatment of substance use disorders, it’s most effective when combined with other therapeutic interventions, such as counseling, behavioral therapies, and supportive services. Decisions about starting MAT should be made collaboratively between the individual and their healthcare provider, considering the person’s unique needs, preferences, and circumstances.